BeiGene initiates first-in-human Phase 1 trial of TYK2 inhibitor BGB-23339
23 November 2021 - 1:06AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
BeiGene (NASDAQ:BGNE)
Historical Stock Chart
From Apr 2024 to May 2024
BeiGene (NASDAQ:BGNE)
Historical Stock Chart
From May 2023 to May 2024